Alexandria Real Estate Equities, Inc. which can be found using ticker (ARE) have now 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $186.00 and $108.00 and has a mean target at $131.92. Given that the stocks previous close was at $130.14 this indicates there is a potential upside of 1.4%. The 50 day MA is $105.30 while the 200 day moving average is $114.92. The total market capitalization for the company now stands at 22.43B. The current share price for the company is: $129.09 USD
The potential market cap would be $22,739,438,233 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 93.54, revenue per share of $16.52 and a 1.23% return on assets.
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company owns, operates, develops and is focused on collaborative life science, agtech, and technology campuses in various cluster locations. It develops urban cluster campuses and ecosystems. Its properties are primarily located in various locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. It has approximately 432 properties in North America containing approximately 47.4 million rentable square feet (RSF) of operating properties and development and redevelopment of new Class A properties (under construction), including 64 properties that are held by consolidated real estate joint ventures and four properties that are held by unconsolidated real estate joint ventures. Its properties include 601, 611, and 651 Gateway Boulevard; Alexandria Center for Life Science-Durham; 275 Grove Street; SD Tech by Alexandria, and Other.
